Validation of the Hebrew version of the Movement Disorder Society-Unified Parkinson's Disease Rating Scale

被引:12
|
作者
Zitser, Jennifer [1 ]
Peretz, Chava [2 ]
David, Aya Ber [1 ]
Shabtai, Herzl [1 ]
Ezra, Adi [1 ]
Kestenbaum, Meir [1 ]
Brozgol, Marina [1 ]
Rosenberg, Alina [2 ]
Herman, Talia [1 ]
Balash, Yakov [1 ]
Gadoth, Avi [1 ]
Thaler, Avner [1 ,5 ]
Stebbins, Glenn T. [3 ]
Goetz, Christopher G. [3 ]
Tilley, Barbara C. [4 ]
Luo, Sheng T. [4 ]
Liu, Yuanyuan [4 ]
Giladi, Nir [1 ,5 ,6 ]
Gurevich, Tanya [1 ,5 ,6 ]
机构
[1] Tel Aviv Med Ctr & Sch Med, Neurol Inst, Movement Disorders Unit, Tel Aviv, Israel
[2] Tel Aviv Univ, Sch Publ Hlth, Sackler Sch Med, Tel Aviv, Israel
[3] Rush Univ, Med Ctr, Dept Neurol Serv, Chicago, IL 60612 USA
[4] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Dept Biostat, Houston, TX 77030 USA
[5] Tel Aviv Univ, Sackler Sch Med, Tel Aviv, Israel
[6] Tel Aviv Univ, Sagol Sch Neurosci, Tel Aviv, Israel
关键词
Parkinson's disease; Rating scales; Clinimetrics; MDS-UPDRS; Validation;
D O I
10.1016/j.parkreldis.2017.09.012
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: The Movement Disorders Society (MDS) published the English new Unified Parkinson's Disease Rating Scale (MDS-UPDRS) as the official benchmark scale for Parkinson's disease (PD) in 2008. We aimed to validate the Hebrew version of the MDS-UPDRS, explore its dimensionality and compare it to the original English one. Methods: The MDS-UPDRS questionnaire was translated to Hebrew and was tested on 389 patients with PD, treated at the Movement Disorders Unit at Tel-Aviv Medical Center. The MDS-UPDRS is made up of four sections. The higher the score, the worst the clinical situation of the patient is. Confirmatory and explanatory factor analysis were applied to determine if the factor structure of the English version could be confirmed in the Hebrew version. Results: The Hebrew version of the MDS-UPDRS showed satisfactory clinimetric properties. The internal consistency of the Hebrew-version was satisfactory, with Cronbach's alpha values 0.79, 0.90, 0.93, 0.80, for parts 1 to 4 respectively. In the confirmatory factor analysis, all four parts had high (greater than 0.90) comparative fit index (CFI) in comparison to the original English MDS-UPDRS with high factor structure (0.96, 0.99, 0.94, 1.00, respectively), thus confirming the pre-specified English factor structure. Explanatory factor analysis yielded that the Hebrew responses differed from the English one within an acceptable range: in isolated item differences in factor structure and in the findings of few items having cross loading on multiple factors. Conclusions: The Hebrew version of the MDS-UPDRS meets the requirements to be designated as the Official Hebrew Version of the MDS-UPDRS. (C) 2017 Elsevier Ltd. All rights reserved.
引用
收藏
页码:7 / 12
页数:6
相关论文
共 50 条
  • [21] Utility of movement disorder society-unified Parkinson's disease rating scale for evaluating effect of subthalamic nucleus deep brain stimulation
    Yamamoto, Tatsuya
    Yamanaka, Yoshitaka
    Hirano, Shigeki
    Higuchi, Yoshinori
    Kuwabara, Satoshi
    FRONTIERS IN NEUROLOGY, 2023, 13
  • [22] Relationship of Movement Disorders Society-Unified Parkinson's Disease Rating Scale Nonmotor Symptoms to Cognitive Functioning in Patients with Parkinson's Disease
    Bernard, Bryan A.
    Carns, Danielle
    Stebbins, Glenn T.
    Goldman, Jennifer G.
    Goetz, Christopher G.
    MOVEMENT DISORDERS CLINICAL PRACTICE, 2020, 7 (03): : 279 - 283
  • [23] Longitudinal Change and Progression Indicators Using the Movement Disorder Society-Unified Parkinson's Disease Rating Scale in Two Independent Cohorts with Early Parkinson's Disease
    Bartl, Michael
    Dakna, Mohammed
    Schade, Sebastian
    Wicke, Tamara
    Lang, Elisabeth
    Ebentheuer, Jens
    Weber, Sandrina
    Trenkwalder, Claudia
    Mollenhauer, Brit
    JOURNAL OF PARKINSONS DISEASE, 2022, 12 (01) : 437 - 452
  • [24] Treatment Detection and Movement Disorder Society-Unified Parkinson's Disease Rating Scale, Part III Estimation Using Finger Tapping Tasks
    ZhuParris, Ahnjili
    Thijssen, Eva
    Elzinga, Willem O. O.
    Makai-Boloni, Soma
    Kraaij, Wessel
    Groeneveld, Geert J. J.
    Doll, Robert J. J.
    MOVEMENT DISORDERS, 2023, 38 (10) : 1795 - 1805
  • [25] Expanded and independent validation of the Movement Disorder Society–Unified Parkinson’s Disease Rating Scale (MDS-UPDRS)
    Pablo Martinez-Martin
    Carmen Rodriguez-Blazquez
    Mario Alvarez-Sanchez
    Tomoko Arakaki
    Alberto Bergareche-Yarza
    Anabel Chade
    Nelida Garretto
    Oscar Gershanik
    Monica M. Kurtis
    Juan Carlos Martinez-Castrillo
    Amelia Mendoza-Rodriguez
    Henry P. Moore
    Mayela Rodriguez-Violante
    Carlos Singer
    Barbara C. Tilley
    Jing Huang
    Glenn T. Stebbins
    Christopher G. Goetz
    Journal of Neurology, 2013, 260 : 228 - 236
  • [26] Inconsistent Movement Disorders Society-Unified Parkinson's Disease Rating Scale Part III Ratings in the Parkinson's Progression Marker Initiative
    Turner, Travis H.
    Dale, Marian L.
    MOVEMENT DISORDERS, 2020, 35 (08) : 1488 - 1489
  • [27] Novel Approach to Movement Disorder Society-Unified Parkinson's Disease Rating Scale Monitoring in Clinical Trials: Longitudinal Item Response Theory Models
    Luo, Sheng
    Zou, Haotian
    Goetz, Christopher G.
    Choi, Dongrak
    Oakes, David
    Simuni, Tanya
    Stebbins, Glenn T.
    MOVEMENT DISORDERS CLINICAL PRACTICE, 2021, 8 (07): : 1083 - 1091
  • [28] Validation of the Hebrew Version of the Unified Dyskinesia Rating Scale
    Faust-Socher, Achinoam
    Anis, Saar
    Kestenbaum, Meir
    Shabtai, Herzl
    Taichman, Tali
    Bar David, Aya
    Ezra, Adi
    Peretz, Chava
    Rosenberg, Alina
    Brozgol, Marina
    Herman, Talia
    Stebbins, Glenn T.
    Goetz, Christopher G.
    Martinez-Martin, Pablo
    Luo, Sheng T.
    Ren, Xuehan
    Giladi, Nir
    Gurevich, Tanya
    NEUROEPIDEMIOLOGY, 2020, 54 (04) : 356 - 361
  • [29] Turkish Standardization of Movement Disorders Society Unified Parkinson's Disease Rating Scale and Unified Dyskinesia Rating Scale
    Akbostanci, Muhittin C.
    Bayram, Ece
    Yilmaz, Volkan
    Rzayev, Sefer
    Ozkan, Serhat
    Tokcaer, Ayse Bora
    Saka, Esen
    Celik, Fatma N. Durmaz
    Barut, Banu Ozen
    Tufekcioglu, Zeynep
    Acarer, Ahmet
    Balaban, Hatice
    Erer, Sevda
    Dogu, Okan
    Kibaroglu, Seda
    Aydin, Nursel
    Hanagasi, Hasmet
    Elibol, Bulent
    Emre, Murat
    Stebbins, Glenn T.
    Goetz, Christopher G.
    MOVEMENT DISORDERS CLINICAL PRACTICE, 2018, 5 (01): : 54 - 59
  • [30] Validation of the Portuguese version of the Movement Disorder Society non-motor rating scale (MDS-NMS) in Parkinson's disease
    Vale, Thiago Cardoso
    Santos, Daniela Pereira
    de Oliveira, Daniel Sabino
    Brandao, Pedro Renato de Paula
    Pereira, Danilo Assis
    Bouca-Machado, Raquel
    Silva, Leonardo Oliveira
    Rieder, Carlos Roberto de Mello
    Barbosa, Egberto Reis
    Cury, Rubens Gisbert
    Parmera, Jacy Bezerra
    Teive, Helio Afonso Ghizoni
    Ferreira, Matheus Gomes
    Ferraz, Henrique Ballalai
    da Silva, Carolina Candeias
    Tumas, Vitor
    Cunha, Ana Luiza Nunes
    Braga-Neto, Pedro
    Lima, Danielle Pessoa
    Della Colleta, Marcus Vinicius
    Maia, Debora
    Fontana, Marco de Souza
    Damas, Catarina N.
    Lobo, Patricia Pita
    Rebordao, Leonor
    Magalhaes, Andreia D.
    Peralta, Ana Rita
    Simoes, Rita M.
    Lampreia, Tania
    Velon, Ana Graca
    Carneiro, Diogo
    Raimundo, Rita
    Gago, Miguel
    Mendes, Alexandre
    Cha, Nuno Vila
    Damasio, Joana
    Costa, Sara
    Lopes, Rui
    Morgadinho, Ana
    Mestre, Tiago
    Stebbins, Glenn T.
    Luo, Sheng
    Goetz, Christopher G.
    Ferreira, Joaquim J.
    Cardoso, Francisco
    PARKINSONISM & RELATED DISORDERS, 2025, 132